Assay Development Screening Hits Small Molecule 
Sygnature Discovery
JUNE 17, 2024
Comprehensive Assay Development for Diverse Applications Our team here at Sygnature Discovery, comprised of expert biophysicists, is highly experienced in a variety of target classes and drug modalities. Sygnature Discovery’s Biophysical Assay Development Capabilities: 1.
Drug Target Review
NOVEMBER 1, 2023
The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. The team that I lead within the CCDD is called the Hit Discovery and Structural Design Team. Although we are an academic centre we work very much like industry.
Expert insights. Personalized for you.
52 
Let's personalize your content